1Kobayashi F,Monma C,Nanbu K,et al.Rapid growth of an ovarian clear cell carcinoma expressing LH/HCG receptor arising from endometriosis during early oregnancy[J].Gynecol Oncol,1996,62:309-313.
2Marhhom E,Cohen I.Fertility preservation options for women with malignancies[J].Obstet Gynecol Surv,2006,62(1):58-72.
3Nguyen C,Montz FJ,Bristow RE.Management of stage I cervical cancer in pregnancy[J].Obstet Gynecol Surv,2000,55:633-643.
4Eppel W,Worda C,Frigo P,et al.Human papillomavirus in the cervix and placenta[J].Obstet Gynecol,2000,96:337-341.
9Paraskevaidis E,Koliopoulos G,Kalantaridou S,et al.Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum[J].Eur J Obstet Gynecol Reprod Biol,2002,104:671.
10Zanetta C,Rota S,Chiari S,et al.Behavior of borderline tumors with particular interest to persistence,recurrence,and progression to invasive carcinoma:a prospective study[J].J Clin Oncol,2001,19:2658.
二级参考文献22
1Duffy MJ,Bonfrer JM,Kulpa J,et al. CAI25 in ovarian cancer:European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer,2005,15 ( 5 ) :679 - 691.
2Bast RC Jr, Badgwell D, Lu Z, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer,2005,15 ( Suppl 3 ) :274- 281.
3Bast RC Jr, Urban N, Shridhar V, et al. Early detection of ovarian cancer: promise and reality. Cancer Treat Res ,2002,107:61-97.
4Gostout BS, Brewer MA. Guidelines for referral of the patient with an adnexal mass. Clin Obstet Gynecol,2006,49 (3) :448-458.
5Kumar P, Rehani MM,Kumar L,et al. Tumor marker CA-I25 as an evaluator and response indicator in ovarian cancer: its quantitative correlation with tumor volume. Med Sci Monit,2005,11 (2) :CR84-89.
6Rustin GJ,Quinn M,Thigpen T, et al. New guidelines to evaluate the response to treatment in solid tumors ( ovarian cancer). J Natl Cancer Inst ,2004,96( 6 ) :487-488.
7Cooper BC, Sood AK, Davis CS, et al. Preoperative CA125 Levels: An Independent Prognostic Factor for Epithelial Ovarian Cancer. Obstet Gynecol,2002,100( 1 ) :59-64.
8Obiezu CV,Scorilas A,Katsaros D,et al. Higher human kallikrein gene 4 ( klk4 ) expression indicates poor prognosis of ovarian cancer patients. Clin Cancer Res,2001,7 ( 8 ) :2380-2386.
9Kim H, Scorilas A, Katsaros D, et al. Human kallikrein gene 5 (KLK.5)expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer,2001,84(5 ) :643-650.
10Kyriakopoulou LG, Yousef GM, Scorilas A, et al. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin Biothem ,2003,36(2) : 135-143.
